Geode Capital Management LLC Raises Stake in HealthEquity, Inc. (NASDAQ:HQY)

Geode Capital Management LLC grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 0.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,078,977 shares of the company's stock after buying an additional 15,145 shares during the quarter. Geode Capital Management LLC owned approximately 2.38% of HealthEquity worth $170,197,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. International Assets Investment Management LLC bought a new stake in HealthEquity during the 2nd quarter worth $35,000. Paladin Wealth LLC bought a new stake in shares of HealthEquity during the third quarter worth about $39,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of HealthEquity in the second quarter valued at approximately $73,000. GAMMA Investing LLC raised its holdings in HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company's stock valued at $77,000 after buying an additional 344 shares during the last quarter. Finally, Quarry LP boosted its position in HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after buying an additional 1,089 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HealthEquity

In other news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,786 shares of company stock valued at $4,140,387. Corporate insiders own 2.20% of the company's stock.

HealthEquity Stock Down 2.6 %

Shares of HQY traded down $2.45 during trading hours on Monday, reaching $93.17. The stock had a trading volume of 935,638 shares, compared to its average volume of 636,079. The firm has a 50-day simple moving average of $94.06 and a 200 day simple moving average of $84.26. HealthEquity, Inc. has a 12 month low of $62.50 and a 12 month high of $105.82. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $8.07 billion, a price-to-earnings ratio of 87.72, a P/E/G ratio of 1.10 and a beta of 0.55.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Royal Bank of Canada raised their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. The Goldman Sachs Group began coverage on HealthEquity in a research report on Friday, November 15th. They set a "neutral" rating and a $108.00 target price for the company. Bank of America upped their price target on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a research report on Wednesday, November 13th. Deutsche Bank Aktiengesellschaft raised their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a "buy" rating in a research report on Wednesday, September 4th. Finally, Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a report on Monday, December 2nd. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.